Yesterday, with the help of a bit of news and a paid pump campaign, Aperture Health, Inc. (PINK:APRE) got a new 52-week volume high.
More than 2.5 million shares changed hands during the session. There was a significant gap up in the beginning, but at the end of the session APRE closed up less than one percent at $0.17 per share.
The company announced that the CEO of Aperture and Triad Therapeutics, Inc. had been certified to provide Medication Therapy Management services to its patients. APRE said it was planning to provide services in the home of its patients, instead of in its facilities.[BANNER]
The other catalyst was the aforementioned paid promotion. IPR Agency LLC was paid $75 thousand for a one-day campaign. IPR has pumped APRE before, and the previous time the effect was short-lived.
A part of the problem with APRE could be that the company is losing money and its balance sheet is significantly leveraged. Unless APRE comes up with further positive news, or better yet – results, it may have difficulties keeping a higher share price.
